首页> 外文期刊>Trials >A randomized controlled trial protocol comparing the feeds of fresh versus frozen mother’s own milk for preterm infants in the NICU
【24h】

A randomized controlled trial protocol comparing the feeds of fresh versus frozen mother’s own milk for preterm infants in the NICU

机译:随机对照试验方案比较新鲜与冷冻母乳的饲料饲料在尼古尔的早产儿

获取原文
           

摘要

Necrotizing enterocolitis (NEC) is the leading cause of death among preterm infants born at ?30?weeks’ gestation. The incidence of NEC is reduced when infants are fed human milk. However, in many neonatal intensive care units (NICUs), it is standard practice to freeze and/or pasteurize human milk, which deactivates bioactive components that may offer additional protective benefits. Indeed, our pilot study showed that one feed of fresh mother’s own milk per day was safe, feasible, and can reduce morbidity in preterm infants. To further evaluate the benefits of fresh human milk in the NICU, a randomized controlled trial is needed. Our prospective multicenter, double-blinded, randomized, controlled trial will include infants born at ?30?weeks’ gestation and admitted to one of 29 tertiary NICUs in China. Infants in the intervention (fresh human milk) group (n?=?1549) will receive at least two feeds of fresh human milk (i.e., within 4?h of expression) per day from the time of enrollment until 32?weeks’ corrected age or discharge to home. Infants in the control group (n?=?1549) will receive previously frozen human milk following the current standard protocols. Following informed consent, enrolled infants will be randomly allocated to the control or fresh human milk groups. The primary outcome is the composite outcome mortality or NEC?≥?stage 2 at 32?weeks’ corrected age, and the secondary outcomes are mortality, NEC?≥?stage 2, NEC needing surgery, late-onset sepsis, retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD), weight gain, change in weight, increase in length, increase in head circumference, time to full enteral feeds, and finally, the number and type of critical incident reports, including feeding errors. Our double-blinded, randomized, controlled trial aims to examine whether fresh human milk can improve infant outcomes. The results of this study will impact both Chinese and international medical practice and feeding policy for preterm infants. In addition, data from our study will inform changes in health policy in NICUs across China, such that mothers are encouraged to enter the NICU and express fresh milk for their infants.
机译:坏死性的小肠结肠炎(NEC)是早产儿出生于<?30?周的妊娠的主要死因。当婴儿喂养人乳时,NEC的发病率降低。然而,在许多新生儿重症监护单位(尼古斯)中,它是冻结和/或巴氏杀菌的标准做法,这使得人牛奶失活,这使得能够提供额外的保护益处的生物活性组件。实际上,我们的试验研究表明,每天的新鲜母乳喂养的饲料是安全,可行的,并且可以降低早产儿的发病率。为了进一步评估新鲜人牛奶在NICU中的益处,需要一种随机对照试验。我们的前瞻性多中心,双盲,随机的受控试验将包括婴儿出生于<?30?周的妊娠,并录取了中国29岁的尼古斯之一。干预婴儿(新鲜的人乳)组(N?= 1549)将每天收到每天至少两种新鲜的人乳(即,在表达中的4℃内),直到32个周为32次纠正年龄或卸货到家。对照组中的婴儿(N?=?1549)将在当前标准方案之后接收先前冷冻的人牛奶。在知情同意之后,注册婴儿将随机分配给控制或新鲜的人牛奶组。主要结果是复合结果死亡率或NEC?≥?阶段2在32?周数的纠正年龄,二次结果是死亡率,NEC?≥?第2阶段,NEC需要手术,晚期发病败血症,早期性败血症( ROP),支气管扩张(BPD),体重增加,重量变化,长度增加,头围的增加,全肠内饲料的时间,最后,临界事件报告的数量和类型,包括喂养误差。我们的双盲,随机,受控试验旨在检查新鲜的人类牛奶是否可以改善婴儿结果。本研究的结果将影响中国和国际医疗实践和早产儿的喂养政策。此外,我们研究中的数据将为中国尼古斯的卫生政策的变化提供信息,因此鼓励母亲进入尼古尔并表达婴儿的新鲜牛奶。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号